Has Lawrence Brzozowski received payments from drug or device companies?

Yes. Drug and device makers reported $7,678 in general payments to Lawrence Brzozowski across 137 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lawrence Brzozowski did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lawrence Brzozowski come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lawrence Brzozowski

Neurology · West Reading, PANPI 1255353306

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.1% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by EMD Serono, Inc. at 26.6% of the total. Reporting peaked in 2019 at $2,683 and has fallen 96.7% since, to $89 in 2025.

$7,678in general payments, 2019–2025

Across 137 payments — averaging $56.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

EMD Serono, Inc.$2K
Teva Pharmaceuticals USA, Inc.$935
Bristol Myers Squibb$720
Biogen$604
Genentech USA, Inc.$573
Amgen$510
plus $2K from 27 others

What the payments were for

Speaking & faculty fees$1732%
Food & beverage$7,37896%
Education$1262%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
EMD Serono, Inc.	39	$2,046
Teva Pharmaceuticals USA, Inc.	10	$935
Bristol Myers Squibb	8	$720
Biogen	7	$604
Genentech USA, Inc.	7	$573
Amgen(2 entities)	5	$510
Sanofi	6	$358
Novartis	10	$358
AbbVie(2 entities)	6	$251
E.r. Squibb & Sons, L.L.C.	4	$249
Acorda Therapeutics, Inc	4	$222
Biohaven Pharmaceutical Holding Company Ltd.	1	$124
Impel Pharmaceuticals Inc.	1	$115
MDD US Operations, LLC	2	$101
SK Life Science, Inc.	2	$80
Supernus Pharmaceuticals, Inc.	3	$66
Eisai Inc.	2	$43
Adamas Pharmaceuticals, Inc.	2	$30
Arbor Pharmaceuticals, Inc.	2	$30
Jazz Pharmaceuticals Inc.	2	$29
Amneal Pharmaceuticals LLC	2	$28
AstraZeneca	1	$28
Argenx US, Inc.	1	$26
Bausch Health US, LLC	1	$22
Greenwich Biosciences, Inc.	1	$22
Promius Pharma LLC	1	$17
Lundbeck LLC	1	$16
Assertio Therapeutics, Inc.	1	$15
Neurocrine Biosciences, Inc.	1	$14
Lilly USA, LLC	1	$13
Acadia Pharmaceuticals Inc	1	$11
Strongbridge US Inc.	1	$11
Akcea Therapeutics, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,678 in reported general payments places this provider in the 75th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania →

Payments from drug & device makers

What this record shows

Who reported the general payments

What the payments were tied to

How this compares

Other neurology in West Reading